Literature DB >> 25311480

Rivaroxaban concentration in patients with deep vein thrombosis who reported thrombus progression or minor hemorrhagic complications: first Polish experience.

Jarosław Zalewski, Radoslaw Rychlak, Tadeusz Góralczyk, Anetta Undas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25311480     DOI: 10.20452/pamw.2470

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


× No keyword cloud information.
  5 in total

1.  Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy.

Authors:  Aleksandra Lenart-Migdalska; Leszek Drabik; Magdalena Kaźnica-Wiatr; Lidia Tomkiewicz-Pająk; Piotr Podolec; Maria Olszowska
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 2.  Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation.

Authors:  Jarosław Zalewski; Anetta Undas
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-11-17       Impact factor: 1.426

3.  Author`s Reply.

Authors:  Ekrem Güler; Gamze Babur Güler; Gültekin Günhan Demir; Suzan Hatipoğlu
Journal:  Anatol J Cardiol       Date:  2016-03       Impact factor: 1.596

4.  Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight.

Authors:  Anetta Undas
Journal:  Anatol J Cardiol       Date:  2016-03       Impact factor: 1.596

5.  Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated Thrombography.

Authors:  Jaroslaw Zalewski; Konrad Stepien; Karol Nowak; Sandi Caus; Saulius Butenas; Anetta Undas
Journal:  J Clin Med       Date:  2020-06-27       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.